Loading…

Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome

Patients with peripheral artery disease (PAD) are known to have an increased risk of ischemic cardiovascular events. However, the influence of concomitant PAD on first and subsequent recurrent ischemic events after an acute coronary syndrome (ACS) remains poorly characterized. We analyzed the combin...

Full description

Saved in:
Bibliographic Details
Published in:The American heart journal 2018-07, Vol.201, p.25-32
Main Authors: Inohara, Taku, Pieper, Karen, Wojdyla, Daniel M., Patel, Manesh R., Jones, William Schuyler, Tricoci, Pierluigi, Mahaffey, Kenneth W., James, Stefan K., Alexander, John H., Lopes, Renato D., Wallentin, Lars, Ohman, Erik Magnus, Roe, Matthew T., Vemulapalli, Sreekanth
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with peripheral artery disease (PAD) are known to have an increased risk of ischemic cardiovascular events. However, the influence of concomitant PAD on first and subsequent recurrent ischemic events after an acute coronary syndrome (ACS) remains poorly characterized. We analyzed the combined data set from 4 randomized trials (PLATO, APPRAISE-2, TRA-CER, and TRILOGY ACS) in ACS for a follow-up length of 1 year. Using multivariable regression, we examined the association between PAD and major adverse cardiovascular events, a composite of cardiovascular death, myocardial infarction, and stroke. Among patients with a nonfatal first event, we evaluated the incidence and type of a second recurrent event. A total of 4,098 of 48,094 (8.5%) post-ACS patients had a history of PAD. The unadjusted frequency of major adverse cardiovascular events was 2-fold higher in patients with PAD (14.3% vs 7.5%) over a median (25th-75th) follow-up of 353 (223-365) days with an adjusted hazard ratio of 1.63 (95% CI: 1.48-1.78; P 
ISSN:0002-8703
1097-6744
1097-6744
DOI:10.1016/j.ahj.2018.03.013